Josie Parker

10PUBLICATIONS
32CO-AUTHORS
Aerospace materialsPlant and fungus systematics and taxonomyMedical infection agents (incl. prions)Medical mycologyMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 21, 2026
Lanosterol synthase inhibition as a potential approach for re-sensitizing triazole-resistant Aspergillus fumigatus.

|Mar 27, 2026
The azole-resistance phenotype of a Nakaseomyces glabratus clinical strain encoding a wild-type PDR1 allele involves the efflux pumps Aus1 and Pdh1 and Cyb5, an alternative reductase required for ergosterol biosynthesis.

Maria Joana Pinheiro, Josie E Parker, Maria T Ferreira

|Sep 22, 2025
Acquired amphotericin B resistance attributed to a mutated ERG3 in Candidozyma auris.

Lauryn Massic, Laura A Doorley, Sarah J Jones

|Aug 27, 2025
Head-to-Head Comparison of Etest, MICRONAUT-AM EUCAST and Reference Broth Microdilution-Based CLSI Results for Candida kefyr Antifungal Susceptibility Testing: Implications for Detection of Reduced Susceptibility to Amphotericin B.

Mohammad Asadzadeh, Suhail Ahmad, Jacques F Meis

|Apr 16, 2025
Acquired Amphotericin B Resistance Attributed to a Mutated ERG3 in Candidozyma auris.

Lauryn Massic, Laura A Doorley, Sarah J Jones

|Jul 09, 2024
Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the Mucor species complex.

María Isabel Navarro-Mendoza, Carlos Pérez-Arques, Josie Parker

Pageof 2

Frequent Collaborators

7 joint publications

Steven L Kelly

4 joint publications

Jeffrey M Rybak

3 joint publications

Jarrod R Fortwendel

2 joint publications

Lauryn Massic